上市医药公司绿色技术创新绩效影响作用分析——以天士力为例

Analysis of the Impact of Green Technology Innovation Performance on Listed Pharmaceutical Companies—Taking Tianshili as an Example

摘要: 随着2020年“双碳”目标的提出。绿色技术创新成为企业履行社会责任、推进企业发展的必经之路。但绿色技术创新存在前期投入大、研发周期长、研发效益不稳定的特点，使得企业在绿色技术创新时频频受阻。因此，本文以天士力集团为例，设计绿色技术创新下企业绩效的评价体系，研究分析绿色技术的研发创新对企业绩效的影响机制，得出存在正相关关系的结论，并从企业、政府及市场的角度对此提出相关建议，希望能为其他企业提供可借鉴的实际意义。

Abstract: With the proposal of the “dual carbon” target for 2020. Green technology innovation has become a necessary path for enterprises to fulfill their social responsibilities and promote their development. However, the characteristics of large initial investment, long R&D cycle, and unstable R&D benefits in green technology innovation have frequently hindered enterprises in green technology innovation. Therefore, taking Tianshili Group as an example, this article designs an evaluation system for enterprise performance under green technology innovation, studies and analyzes the impact mechanism of green technology research and development innovation on enterprise performance, draws the conclusion that there is a positive correlation, and puts forward relevant suggestions from the perspectives of enterprises, governments, and markets, hoping to provide practical significance for other enterprises to learn from.